Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huperzine A for Postoperative Delirium in Elderly Patients
NCT05242419Recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Jun 2022
- Primary completion
- Nov 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Huperzine A in postoperative delirium (POD) (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Incidence of delirium within 7 days after operation. Started Jun 2022; status: recruiting.
02
Drugs
Huperzine A
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05242419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05242419.